BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18406011)

  • 1. Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model.
    Karuppagounder SS; Xu H; Shi Q; Chen LH; Pedrini S; Pechman D; Baker H; Beal MF; Gandy SE; Gibson GE
    Neurobiol Aging; 2009 Oct; 30(10):1587-600. PubMed ID: 18406011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development.
    Zhang XM; Cai Y; Xiong K; Cai H; Luo XG; Feng JC; Clough RW; Struble RG; Patrylo PR; Yan XX
    Eur J Neurosci; 2009 Dec; 30(12):2271-83. PubMed ID: 20092570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiamine deficiency increases β-secretase activity and accumulation of β-amyloid peptides.
    Zhang Q; Yang G; Li W; Fan Z; Sun A; Luo J; Ke ZJ
    Neurobiol Aging; 2011 Jan; 32(1):42-53. PubMed ID: 19233513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disturbances of the blood-brain barrier without expression of amyloid precursor protein- containing neuritic clusters or neuronal loss during late stages of thiamine deficiency in guinea pigs.
    Calingasan NY; Park LC; Gandy SE; Gibson GE
    Dev Neurosci; 1998; 20(4-5):454-61. PubMed ID: 9778584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
    Devi L; Ohno M
    Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.
    Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R
    Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocation of amyloid precursor protein C-terminal fragment(s) to the nucleus precedes neuronal death due to thiamine deficiency-induced mild impairment of oxidative metabolism.
    Karuppagounder SS; Xu H; Pechman D; Chen LH; DeGiorgio LA; Gibson GE
    Neurochem Res; 2008 Jul; 33(7):1365-72. PubMed ID: 18317926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel neuritic clusters with accumulations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency.
    Calingasan NY; Gandy SE; Baker H; Sheu KF; Smith JD; Lamb BT; Gearhart JD; Buxbaum JD; Harper C; Selkoe DJ; Price DL; Sisodia SS; Gibson GE
    Am J Pathol; 1996 Sep; 149(3):1063-71. PubMed ID: 8780408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology.
    Rossner S; Apelt J; Schliebs R; Perez-Polo JR; Bigl V
    J Neurosci Res; 2001 Jun; 64(5):437-46. PubMed ID: 11391698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases.
    Wirths O; Bethge T; Marcello A; Harmeier A; Jawhar S; Lucassen PJ; Multhaup G; Brody DL; Esparza T; Ingelsson M; Kalimo H; Lannfelt L; Bayer TA
    J Neural Transm (Vienna); 2010 Jan; 117(1):85-96. PubMed ID: 19823761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology.
    Peters F; Salihoglu H; Rodrigues E; Herzog E; Blume T; Filser S; Dorostkar M; Shimshek DR; Brose N; Neumann U; Herms J
    Acta Neuropathol; 2018 May; 135(5):695-710. PubMed ID: 29327084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice.
    Dewachter I; Reversé D; Caluwaerts N; Ris L; Kuipéri C; Van den Haute C; Spittaels K; Umans L; Serneels L; Thiry E; Moechars D; Mercken M; Godaux E; Van Leuven F
    J Neurosci; 2002 May; 22(9):3445-53. PubMed ID: 11978821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology.
    Apelt J; Bigl M; Wunderlich P; Schliebs R
    Int J Dev Neurosci; 2004 Nov; 22(7):475-84. PubMed ID: 15465277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral treatment with enoxaparin exacerbates amyloid plaque pathology in Tg2576 mice.
    Cui H; King AE; Jacobson GA; Small DH
    J Neurosci Res; 2017 Apr; 95(4):992-999. PubMed ID: 27546887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis.
    O'Connor T; Sadleir KR; Maus E; Velliquette RA; Zhao J; Cole SL; Eimer WA; Hitt B; Bembinster LA; Lammich S; Lichtenthaler SF; Hébert SS; De Strooper B; Haass C; Bennett DA; Vassar R
    Neuron; 2008 Dec; 60(6):988-1009. PubMed ID: 19109907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
    Cai Z; Wang C; He W; Chen Y
    Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
    Yang H; Yang H; Xie Z; Wang P; Bi J
    Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP/Ld transgenic mouse model of Alzheimer's disease.
    Kukreja L; Kujoth GC; Prolla TA; Van Leuven F; Vassar R
    Mol Neurodegener; 2014 May; 9():16. PubMed ID: 24885175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.